<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 13, 1995
Health-Chem Corporation
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation)
1-6787 13-2682801
(Commission File Number) (IRS Employer Identification No.)
1212 Avenue of the Americas, New York, NY 10036
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (212) 398-0700
<PAGE>
Item 4. Changes in Registrant's Certifying Accountant
(a) Effective November 13, 1995, the Board of Directors of Health-
Chem Corporation (the "Company") approved the recommendation
of the Company's Audit Committee to appoint the accounting
firm of Coopers & Lybrand as independent accountants for the
Company for the year ending December 31, 1995. The audit work
of Deloitte & Touche LLP was terminated as of November 13,
1995.
(b) During the two most recent fiscal years and the subsequent
interim period preceding the termination of Deloitte & Touche
LLP, there have been no disagreements with Deloitte & Touche
LLP on any matter of accounting principles or practices,
financial statement disclosure, or auditing scope or procedure
or any reportable events.
(c) Deloitte & Touche LLP's report on the financial statements for
the past two years contained no adverse opinion or disclaimer
of opinion and was not qualified or modified as to
uncertainty, audit scope or accounting principles.
(d) The Company has requested that Deloitte & Touche LLP furnish
it with a letter addressed to the SEC stating whether it
agrees with the above statements. A copy of Deloitte & Touche
LLP's letter to the SEC, dated November 14, 1995, is filed as
Exhibit 16 to the Form 8-K.
<PAGE>
Item 7. Financial Statements and Exhibits
(a) Financial Statements
None
(b) Pro Forma Financial Information
None
(c) Exhibits
16.1 Letter re Change in Certifying Accountant
SIGNATURE
Pursuant to the requirements of the Securities and Exchange
Act of 1934, the Registrant has duly caused this report to be
signed on its behalf by the undersigned thereunto duly authorized.
HEALTH-CHEM CORPORATION
Date: October 20, 1995 By: /s/ Robert D. Speiser
Robert D. Speiser
Executive Vice President
<PAGE>
November 14, 1995
Securities and Exchange Commission
Mail Stop 9-5
450 5th Street, N.W.
Washington, DC 20549
Dear Sirs/Madams:
We have read and agree with the comments in Item 4 of Form 8-K of
Health-Chem Corporation dated November 13, 1995.
Yours truly,
DELOITTE & TOUCHE LLP
